ArticleBritish journal of cancer2022

Discovery and validation of a transcriptional signature identifying homologous recombination-deficient breast, endometrial and ovarian cancers.

Guillaume Beinse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.